title: [Significance of serum type III procollagen N-terminal peptide in patients with fibrotic lung disease].
authors.forename: S
authors.initials: S
authors.lastname: Tanigawa
authors.forename: Y
authors.initials: Y
authors.lastname: Kinoshita
authors.forename: H
authors.initials: H
authors.lastname: Kurosu
authors.forename: M
authors.initials: M
authors.lastname: Mogi
authors.forename: M
authors.initials: M
authors.lastname: Masutani
authors.forename: H
authors.initials: H
authors.lastname: Hayashi
authors.forename: M
authors.initials: M
authors.lastname: Okayasu
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood; D008297:Male; D008875:Middle Aged; D008995:Monoamine Oxidase / Q000097:blood; D010446:Peptide Fragments / Q000097:blood*; D011009:Pneumoconiosis / Q000097:blood; D011347:Procollagen / Q000097:blood*; D011658:Pulmonary Fibrosis / Q000097:blood*; D012507:Sarcoidosis / Q000097:blood
chemical_list: D010446:Peptide Fragments; D011347:Procollagen; C041876:procollagen Type III-N-terminal peptide; D008995:Monoamine Oxidase